Patricia Stewart, MD
Allergy & Immunology · Madison, MSNPI 1689803918
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $138,463 of the $214,635 with a category attached, or 64.5%. 26 manufacturers reported payments, led by Biocryst US Sales Co., LLC at 58.0% of the total. 2025 is the largest year on record at $67,607, 4.2 times the $16,070 reported in 2019. Among allergy & immunology clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 371 payments — averaging $578.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biocryst US Sales Co., LLC$124K
- CSL Behring$36K
- Genentech USA, Inc.$31K
- Novartis$16K
- GSK$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- plus $3K from 20 others
What the payments were for
- Consulting fees$42,38820%
- Speaking & faculty fees$138,46365%
- Travel & lodging$25,23612%
- Food & beverage$8,4204%
- Education$1280%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biocryst US Sales Co., LLC | 99 | $124,441 |
| CSL Behring | 67 | $36,273 |
| Genentech USA, Inc. | 36 | $30,993 |
| Novartis | 23 | $15,841 |
| GSK | 38 | $2,597 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $1,568 |
| AstraZeneca | 37 | $1,111 |
| Regeneron Healthcare Solutions, Inc. | 19 | $494 |
| Sanofi | 8 | $350 |
| Galderma Laboratories, L.p. | 6 | $174 |
| Ionis Pharmaceuticals, Inc. | 4 | $129 |
| QOL Medical, LLC | 6 | $122 |
| Blueprint Medicines Corporation | 3 | $78 |
| Biocryst Pharmaceuticals, Inc. | 1 | $70 |
| Grifols USA, LLC | 4 | $69 |
| Pharming Healthcare, Inc. | 3 | $66 |
| Incyte Corporation | 1 | $55 |
| Amgen | 3 | $46 |
| Pfizer | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Shire North American Group Inc | 1 | $24 |
| LEO Pharma Inc. | 1 | $23 |
| Insmed, Inc. | 1 | $17 |
| Organon | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$214,635 in reported general payments places this provider in the 95th percentile of 28 allergy & immunology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrladeyoBerotralstat Hydrochloride | 29 | $1,225,729 |
| HaegardaC1 Esterase Inhibitor | 13 | $818,105 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 38 | $243,171 |
| Dupixent SyringeDupilumab | 19 | $71,009 |
| Dupixent PenDupilumab | 12 | $46,347 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $45,297 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 20 | $13,032 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $8,957 |
| Spiriva RespimatTiotropium Bromide | 17 | $8,614 |
| Azelastine Hcl | 108 | $4,812 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $3,338 |
| Epinephrine | 21 | $3,248 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 17 | $2,902 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 89 | $2,407 |
| Ipratropium Bromide | 63 | $2,026 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Biocryst US Sales Co., LLCOrladeyo | $124,441 | $1,225,72929 claims |
| CSL BehringHaegarda, Hizentra | $36,273 | $1,061,27651 claims |
| GSKTrelegy Ellipta | $2,597 | $45,29733 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,111 | $12,29628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 28 allergy & immunology providers in Mississippi.
Other allergy & immunology in Madison
- Natalie RudsenskeMadison$3K
- Todd AdkinsJackson$226K
- Daniel VenarskeJackson$156K
- Dexter WalcottJackson$154K
- Chelle WilhelmJackson$61K
- Mark MurrayDiberville$41K
- Stephen LeblancMeridian$34K
- Jennifer OlivierPicayune$24K
- Joshua PhillipsJackson$20K
- Matthew OswaltTupelo$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.